Advanced colorectal cancer Trials in Shanghai, China
Conditions / Advanced colorectal cancer / Shanghai, China
Research into Advanced colorectal cancer spans multiple therapeutic approaches and trial phases.
11 total trials for this combination
Showing top 10 of 11 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT04793958 | Phase 3 Study of MRTX849 With Cetuximab vs Chemotherapy in Patients With Advanced Colorectal Cancer With KRAS G12C Mutation (KRYSTAL-10) | ACTIVE_NOT_RECRUITING | — |
| NCT03126071 | Raltitrexed-based Chemotherapy Plus Bevacizumab in Retreated Patients With Advanced Colorectal Cancer | UNKNOWN | PHASE2 |
| NCT05495672 | Circulating Tumor DNA Guided Therapeutic Strategies for CRC Patients With Small Pulmonary Nodules | UNKNOWN | NA |
| NCT06601075 | The Role of 18F-FDG and 68Ga-FAPI PET/CT in the Diagnosis and the Efficacy Evaluation of Advanced Colorectal Cancer (peritoneal Metastasis With/without Other Metastases) | RECRUITING | — |
| NCT00853684 | Oxaliplatin, Capecitabine and Endostar as First Line Treatment for Patients With Advanced Colorectal Cancer | UNKNOWN | PHASE2 |
| NCT04793958 | Phase 3 Study of MRTX849 With Cetuximab vs Chemotherapy in Patients With Advanced Colorectal Cancer With KRAS G12C Mutation (KRYSTAL-10) | ACTIVE_NOT_RECRUITING | — |
| NCT04793958 | Phase 3 Study of MRTX849 With Cetuximab vs Chemotherapy in Patients With Advanced Colorectal Cancer With KRAS G12C Mutation (KRYSTAL-10) | ACTIVE_NOT_RECRUITING | — |
| NCT05194995 | JAB-21822 in Combination With Cetuximab in Patients With Advanced CRC and Other Solid Tumors With KRAS G12C Mutation | ACTIVE_NOT_RECRUITING | PHASE1/PHASE2 |
| NCT06885385 | A Phase 2 Study Evaluating the Safety and Efficacy of JS207 With or Without JS015 in Combination With Chemotherapy in Patients With Colorectal Cancer | RECRUITING | PHASE2 |
| NCT05028933 | IMC001 for Clinical Research on Advanced Digestive System Malignancies | UNKNOWN | PHASE1 |